Publicacions en col·laboració amb investigadors/es de University of Leicester (11)

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. A genome-wide association study of survival in patients with sepsis

    Critical Care, Vol. 26, Núm. 1

  3. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions

    Journal of Neurology, Vol. 269, Núm. 5, pp. 2265-2274

  4. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2019

  1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

2016

  1. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia

    Leukemia, Vol. 30, Núm. 11, pp. 2179-2186

  2. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

2013

  1. β-defensin genomic copy number does not influence the age of onset in huntington’s disease

    Journal of Huntington's Disease, Vol. 2, Núm. 1, pp. 107-124

2012

  1. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma

    British Journal of Haematology, Vol. 158, Núm. 6, pp. 712-726

2010

  1. Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): Results from the phase II EUR018 trial

    Annals of Oncology, Vol. 21, Núm. 7, pp. 1492-1499

  2. Quality, quantity and harmony: The DataSHaPER approach to integrating data across bioclinical studies

    International Journal of Epidemiology, Vol. 39, Núm. 5, pp. 1383-1393